Lataa...
Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients
AIM: To study the efficacy and safety of entecavir (ETV) as first-line therapy for hepatitis B virus (HBV) reactivation due to immunosuppression. METHODS: Four patients that were treated with different immunosuppressive regimens for hematological malignancies, who presented with HBV reactivation wer...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Co., Limited
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2988237/ https://ncbi.nlm.nih.gov/pubmed/21086562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v16.i43.5447 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|